Zydus Lifesciences Ltd announced that it will acquire Sterling Biotech's 'Target Business', which is principally engaged in the manufacturing process of fermentation-based active pharmaceutical ingredients products, as well as a production facility..
Max Healthcare has announced a strategic partnership with Lakshdeep Group to obtain a majority share in Jaypee Healthcare, which is currently in Corporate Insolvency Resolution Process (CIRP). The purchase is valued at Rs 1,660 crore in terms of...
Eli Lilly announced that it will invest $1.8 billion in two manufacturing facilities in Ireland to increase production of its highly popular obesity medication and a recently approved treatment for Alzheimer's disease. The funding is a...
Strides Pharma Science announced that it has gained approval from both equity shareholders and secured creditors to establish OneSource, a specialized pharmaceutical Contract Development and Manufacturing Organization (CDMO). In a statement...
Bharat Biotech and Alopexx, Inc. are partnering to develop and sell AV0328, a broad-spectrum anti-microbial vaccine, in India and other low and lower middle-income nations. A statement from the vaccine manufacturer based in...
The pharmaceutical company announced that its subsidiary, Eugia Steriles, received approval from the USFDA for its first product, Lidocaine Hydrochloride injection. Lidocaine is a numbing medication used as a local anesthetic to reduce pain or...
The Indian pharmaceutical sector is set to bolster its position in the global market, said K Raja Bhanu, director general of the Pharmaceuticals Export Promotion Council of India (Pharmexcil). During the closing day of iPHEX 2024, Bhanu emphasized...
Driven by global demand, generics production, and increased domestic investment, India's pharma manufacturing sector has grown by 9% to 12% annually over the past two years. Automation in the industry has also surged, with 15% to 18% annual growth.
The pharma industry is undergoing a transformative evolution with the integration of advanced manufacturing technologies and automation systems. In the 2-day program 6th Annual Pharma Manufacturing and Automation Convention 2024.
In an interaction with India Pharma Outlook, Satish Agrawal, President (Tech & Operations) at Ajanta Pharma, shares his views
, CDSCO.jpg)
